Iran Press/ Iran News: Speaking at the fourth Mustafa Prize Science Promotion Meeting, which was held in Tehran on Monday, the Director of Biotechnology Department of Razi Institute Central Laboratory and Conductor of recombinant coronavirus vaccine, Reza Banihashemi, stated that the Iranian made vaccine will activate the immune system, and it is not harmful.
It is possible to inject the vaccine to all age groups, even pregnant women and children, he noted.
Coronavirus vaccine, which Razi institute produces, includes both injection and inhalation with the minimum injection doze, a new recombinant vaccine in the world, Banihashemi stated.
The conductor of coronavirus vaccine based on recombinant protein noted that in pre-clinical trials, Razi’s vaccine has been tested for 9 to 10 months and has shown immunity in this period.
Razi’s coronavirus vaccine enters its clinical trial from next week, Banihashemi concluded.
214/206
Read More:
Over 10 million COVID-19 tests conducted across Iran
